Skip to main content
. 2020 Oct 6;4(5):565–574. doi: 10.1016/j.mayocpiqo.2020.05.005

Table 2.

Favored Prebiopsy Clinical Diagnosisa,b

Diagnosis Total (N=271) TBFB (n=151) TBCB (n=120) P valuec
Granulomatous, noninfectiousd 133 (49) 76 (50) 57 (48) .64
Non-IPF fibrotic ILDe 66 (24) 28 (19) 38 (32) .012
Infectionf 60 (22) 46 (31) 14 (12) <.001
Organizing pneumoniag 53 (20) 36 (24) 17 (14) .046
Indeterminate ILDh 52 (19) 31 (21) 21 (18) .53
IPF/UIPi 33 (12) 10 (7) 23 (19) .002
Eosinophilic pneumonia 29 (11) 23 (15) 6 (5) .007
Neoplasmj 27 (10) 14 (9) 13 (11) .67
Vasculitis 21 (8) 13 (9) 8 (7) .55
RB-ILD/DIP 19 (7) 10 (7) 9 (8) .78
Aspirationk 17 (6) 5 (3) 12 (11) .024
pLCH 4 (2) 3 (2) 1 (0.8) .43
DAH 6 (2) 4 (3) 2 (2) .59
Amyloid 3 (1) 1 (0.7) 2 (2) .43
CHFl 3 (1) 2 (1) 1 (0.8) .70
Bronchiolitis 3 (1) 2 (1) 1 (0.8) .70
PAP 3 (1) 2 (1) 1 (0.8) .70
LAM 1 (0.4) 1 (0.7) 0 .37
Pneumoconiosis 1 (0.4) 1 (0.7) 0 .37
a

CHF = congestive heart failure; DAH = diffuse alveolar hemorrhage; DIP = desquamative interstitial pneumonia; ILD = interstitial lung disease; IPF = idiopathic pulmonary fibrosis; LAM = lymphangioleiomyomatosis; NSIP = nonspecific interstitial pneumonia; PAP = pulmonary alveolar proteinosis; pLCH = pulmonary Langerhans cell histiocytosis; RB-ILD = respiratory bronchiolitis-interstitial lung disease; TBCB = transbronchial cryobiopsy; TBFB = transbronchial forceps biopsy; UIP = usual interstitial pneumonia.

b

Data are presented as No. (percentage).

c

Chi-square test.

d

Noninfectious granulomatous process, eg, sarcoidosis (well-formed noncaseating granulomas), hypersensitivity pneumonitis (poorly formed granulomas, lymphocytic interstitial infiltrates, and cellular bronchiolitis).

e

Non-IPF fibrotic ILD such as NSIP.

f

Infections presenting as ILD (eg, Cytomegalovirus pneumonia).

g

Organizing pneumonia, eg, cryptogenic organizing pneumonia, connective tissue disease–associated ILD, and drug-induced lung disease.

h

Indeterminate clinicoradiographic pattern.

i

Cases in which a radiographic pattern consistent with UIP and clinical diagnosis with IPF.

j

Neoplastic diseases presenting as ILD (eg, lymphangitis carcinomatosis and lymphoproliferative diseases).

k

Aspiration (eg, food or vegetable matter with pneumonia).

l

Congestive heart failure presenting as ILD.